MEDA Pharma GmbH & Co. KG
- Address
- Benzstrasse 1
Sponsor Overview
Specializations
Pancreatic Exocrine Insufficiency after Pancreatic Surgery
Research activity includes adults living with pancreatic exocrine insufficiency following total pancreatectomy, with attention to the ongoing need for pancreatic enzyme replacement therapy in post-surgical care.
- Post-pancreatectomy digestive support
- Pancreatic enzyme replacement therapy
- Exocrine pancreatic function
The therapeutic focus extends to managing malabsorption-related symptoms and supporting nutritional intake in patients with loss of pancreatic enzyme production.
Cystic Fibrosis and Digestive Enzyme Deficiency
Clinical research also involves patients with cystic fibrosis who experience pancreatic exocrine insufficiency, reflecting interest in the gastrointestinal and nutritional burden associated with the disease.
- CF-related pancreatic insufficiency
- Gastrointestinal symptom control
- Nutritional management
These studies are centered on the practical use of enzyme-based treatment in a chronic inherited disorder with significant digestive involvement.
Pancreatic Enzyme Replacement Therapy
The sponsor’s research landscape is closely tied to pancreatic enzyme replacement therapy, with interest in treatment acceptability and the role of enzyme supplementation in daily meal-related care.
- Enzyme supplementation
- Meal-related treatment use
- Patient acceptability
This area reflects a therapeutic emphasis on improving the usability of enzyme therapy for patients who depend on it for digestion and nutrient absorption.
Sponsored Trials
| Trial Name | Country | Status |
|---|---|---|
| Evaluation of Pancreatic Enzyme Replacement Therapy with Pancreas Powder in Pancreatic Exocrine Insufficiency Post-Pancreatectomy |  Austria Germany Poland Spain | Recruiting |
| Evaluation of Patient Acceptability of a New Pancreas Powder Formulation in Cystic Fibrosis Patients with Pancreatic Exocrine Insufficiency | Germany | Not Recruiting |
Data & Insights
This sponsor works with 1 molecule, of which 0 are not being studied by other sponsors.
This sponsor has worked with 33 sites across their trial portfolio.
Therapeutic Focus
- 1.Digestive System Diseases1 trial280 other sponsors
- 2.Respiratory Tract Diseases1 trial277 other sponsors
Partnered Research Centres
33 centres- Address
- Carrer De La Feixa Llarga S/N, 08907 L'hospitalet De Llobregat
- Address
- Hindenburgdamm 30, Lichterfelde, 12203 Berlin
- Address
- Spandauer Damm 130, 14050 Berlin
- Address
- Heusnerstrasse 40, Barmen, 42283 Wuppertal
- Address
- Carrer De San Quinti 89, 08041 Barcelona
- Address
- Calle Del Doctor Esquerdo 46, 28007 Madrid
Want to get in touch with this sponsor?
Send a question and we'll pass it on to MEDA Pharma GmbH & Co. KG.
Need a custom report on this sponsor?
Competitive positioning, market entry, partnership opportunities — tell us the question.
Is something out of date?
Tell us what needs correcting and we'll update this profile.